These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25271433)

  • 1. Progress in lipid-based nanoparticles for cancer therapy.
    Grinberg S; Linder C; Heldman E
    Crit Rev Oncog; 2014; 19(3-4):247-60. PubMed ID: 25271433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles.
    Alavi M; Hamidi M
    Drug Metab Pers Ther; 2019 Feb; 34(1):. PubMed ID: 30707682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics.
    Date T; Nimbalkar V; Kamat J; Mittal A; Mahato RI; Chitkara D
    J Control Release; 2018 Feb; 271():60-73. PubMed ID: 29273320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronate-Lipid Nanohybrids: Fruitful Harmony in Cancer Targeting.
    Freag MS
    Curr Pharm Des; 2017; 23(35):5283-5291. PubMed ID: 28552066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric nanoparticles for cancer therapy.
    Parveen S; Sahoo SK
    J Drug Target; 2008 Feb; 16(2):108-23. PubMed ID: 18274932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
    Pridgen EM; Langer R; Farokhzad OC
    Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy.
    Du JZ; Mao CQ; Yuan YY; Yang XZ; Wang J
    Biotechnol Adv; 2014; 32(4):789-803. PubMed ID: 23933109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery approaches for breast cancer.
    Singh SK; Singh S; Lillard JW; Singh R
    Int J Nanomedicine; 2017; 12():6205-6218. PubMed ID: 28883730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.
    Chen B; Dai W; He B; Zhang H; Wang X; Wang Y; Zhang Q
    Theranostics; 2017; 7(3):538-558. PubMed ID: 28255348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.
    Yingchoncharoen P; Kalinowski DS; Richardson DR
    Pharmacol Rev; 2016 Jul; 68(3):701-87. PubMed ID: 27363439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.
    Ho BN; Pfeffer CM; Singh ATK
    Anticancer Res; 2017 Nov; 37(11):5975-5981. PubMed ID: 29061776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered nanoparticles for drug delivery in cancer therapy.
    Sun T; Zhang YS; Pang B; Hyun DC; Yang M; Xia Y
    Angew Chem Int Ed Engl; 2014 Nov; 53(46):12320-64. PubMed ID: 25294565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral delivery of anticancer drugs III: formulation using drug delivery systems.
    Mazzaferro S; Bouchemal K; Ponchel G
    Drug Discov Today; 2013 Jan; 18(1-2):99-104. PubMed ID: 22981667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution of lipid nanoparticles: a comparative study of pulmonary versus intravenous administration in rats.
    Videira MA; Santos AC; Botelho MF
    Curr Radiopharm; 2012 Apr; 5(2):158-65. PubMed ID: 22280113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.
    Ramishetti S; Huang L
    Ther Deliv; 2012 Dec; 3(12):1429-45. PubMed ID: 23323560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide targeted lipid nanoparticles for anticancer drug delivery.
    Pearce TR; Shroff K; Kokkoli E
    Adv Mater; 2012 Jul; 24(28):3803-22, 3710. PubMed ID: 22674563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
    Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
    Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents.
    Maranhão RC; Vital CG; Tavoni TM; Graziani SR
    Expert Opin Drug Deliv; 2017 Oct; 14(10):1217-1226. PubMed ID: 28042707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-specific uptake of anti-cancer drugs: the future is here.
    Caraglia M; Marra M; Misso G; Lamberti M; Salzano G; De Rosa G; Abbruzzese A
    Curr Drug Metab; 2012 Jan; 13(1):4-21. PubMed ID: 22292808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.